AFArwa Ali A. Faizo

Arwa Ali A. Faizo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Arwa Ali A. Faizo has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Putative herbal drugs for targeting infection and inflammatory diseases: Network pharmacological application in case of Zika virus and Dengue virus infections

    by Raja Jeet, Arwa Faizo, Mai El-Daly, Aiah Khateb, Sarah Altwaim, Ahmad Ashshi, Manal Tashkandi, Mohammad Mobashir, Esam Azhar

    Inflammation is the primary cause of many human diseases, including the Zika virus, Dengue infection, COVID-19 infection, asthma, rheumatoid arthritis, inflammatory bowel disease, Crohn’s disease, and tendinitis. Other diseases that are closely related to Dengue and Zika are also carried by the same kind of mosquitoes. Zika epidemics in human populations have just recently happened, but dengue fever is well-known and has long impacted people globally. When the inflammatory process is under control, it helps keep the body from disintegrating catastrophically; when it is not, it damages the body and results in unintentional deterioration. Given the importance of the pathways linked to inflammation, we have thus chosen to do research that may enable us to understand the function of these pathways and their constituent parts in cases of Dengue and Zika virus infection, as well as possible targets for herbal remedies. For a very long time, people have employed herbal treatments to treat or prevent ailments, including inflammatory problems. They are also an invaluable source of chemical building blocks that have developed into medicines that are necessary for contemporary health. It is of potential interest to understanding the gene expression patterns and the altered biological functions as a result of infection and to predict the potential drugs and the targets. Thus, to target those pathways using herbal drugs, we may have primarily investigated the shared/common pathways and the genes that comprise those processes in this study. By using in-silico approach, we have compared gene expression profiling, pathway enrichment analysis, network-level comprehension, projected potential genes and pathways, and performed docking for the top genes/proteins to predict the potential herbal drugs and the targets in order to achieve this using an integrated computational approach. Based on our analysis, we conclude that a large fraction of ZIKV and DENV DEGs overlap, and that all of the DENV-induced altered pathways exclusively belong to the ZIKV altered pathway list in terms of biological functions. These findings suggest that ZIKV and DENV infections are highly similar in terms of gene expression and possibly altered biological function levels. Furthermore, we performed docking profiling of the proteins inferred to chosen DEGs based on network analysis against the herbal medicines in order to discover potential targets for ZIKV and DENV infections with herbal medications. Fisetin appears to be the most promising among the three drugs selected with respect to Querceting and apigenin.

  • Open Access

    A computational approach reveals the critical role of PARK2 gene and the potential infectious pathways and HPV infection in colorectal cancer

    by Leena Bajrai, Thamir Alandijany, Arwa Faizo, Isra Alsaady, Raja Jeet, Mohammad Mobashir, Esam Azhar

    Colorectal cancer is a type of cancer that begins in the colon or rectum, and it is also known as colon cancer or rectal cancer, depending on where it begins. Colorectal cancer is one of the most common and deadly cancers, with a wide range of outcomes and medication responses. The human papillomavirus produces benign and malignant neoplasms in epidermal and mucosal epithelial cells. HPVs that are often found in anogenital malignancies, particularly cancers of the cervix and anus, are classified as high-risk or oncogenic. The PARK2 gene is one of the most important genes known to be linked to the ubiquitin proteasomal system and to play a role in cancer and other serious disorders. In order to comprehend the genotype-phenotype relationship in complicated disorders, high-throughput data (genomic and proteomic) is commonly collected. In this study, we focused on the relationship between the human papillomavirus, the PARK2 gene, gene expression patterns, altered genes, and their activities in colorectal cancer. We got the data from a publically available database for gene expression, mutations, and structural variants in human colorectal cancer for this study. We looked at it in terms of clinical importance by combining the Gene Expression Omnibus, TCGA, and ProteinAtlas datasets. According to our findings, the PARK2 gene impacts not only the ubiquitin proteasomal systems, but also key pathways, particularly those involved with the immune system, which may be directly responsible for colorectal and other types of cancer, as well as other key human disorders. Furthermore, it demonstrates that the HPV-infected genes and their estimated roles were potentially shared with genes that are important components of well-known colorectal cancer control and coordination pathways.

  • Open Access

    Human papillomavirus type 16 infection activates the host serine arginine protein kinase 1 (SRPK1) – splicing factor axis

    by Sarah Mole, Arwa Ali A. Faizo, Hegel Hernandez-Lopez, Megan Griffiths, Andrew Stevenson, Sally Roberts, Sheila V Graham

    The infectious life cycle of human papillomaviruses (HPVs) is tightly linked to keratinocyte differentiation. Evidence suggests a sophisticated interplay between host gene regulation and virus replication. Alternative splicing is an essential process for host and viral gene expression, and is generally upregulated by serine arginine-rich splicing factors (SRSFs). SRSF activity can be positively or negatively controlled by cycles of phosphorylation/dephosphorylation. Here we show that HPV16 infection leads to accumulation of the paradigm SRSF protein, SRSF1, in the cytoplasm in a keratinocyte differentiation-specific manner. Moreover, HPV16 infection leads to increased levels of cytoplasmic and nuclear phosphorylated SRSF1. SR protein kinase 1 (SRPK1) phosphorylates SRSF1. Similar to HPV upregulation of SRSF1, we demonstrate HPV upregulation of SRPK1 via the viral E2 protein. SRPK1 depletion or drug inhibition of SRPK1 kinase activity resulted in reduced levels of SRSF1, suggesting that phosphorylation stabilizes the protein in differentiated HPV-infected keratinocytes. Together, these data indicate HPV infection stimulates the SRPK1–SRSF axis in keratinocytes.